At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 32 enrolled
Drug / intervention
BI 409306 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Male and Female Subjects
In Brief
A Phase 1 clinical trial evaluating BI 409306 and Donepezil for Healthy. Completed, enrolled 32 participants across 1 site.
Detailed Summary
Part I: To investigate whether and to what extent donepezil affects single dose pharmacokinetics of BI 409306 Part II: To investigate whether and to what extent BI 409306 affects the single dose pharmacokinetics of donepezil
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartJan 2016
Primary CompletionMar 2016
Study CompletionApr 2016
TodayJul 2026
First PostedDec 21, 2015
Enrollment StartJan 15, 2016
Primary CompletionMar 16, 2016
Study CompletionApr 4, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.5 years ago
Interventions
BI 409306drug
Donepezildrug